Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Obstetrics & Gynecology 1985;65:264-270
© 1985 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SWENERTON, K D
Right arrow Articles by BOYES, D A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SWENERTON, K D
Right arrow Articles by BOYES, D A

Ovarian Carcinoma: A Multivariate Analysis of Prognostic Factors

K D SWENERTON, MD, T G HISLOP, MD, MSC, J. SPINELLI, MSC, J C LeRICHE, MD, N. YANG, BSC and D A BOYES, MD

From the A. Maxwell Evans Clinic of the Cancer Control Agency British Columbia, Vancouver, Canada

Abstract

Five hundred and fifty six women with invasive epithelial ovarian carcinoma were assessed for postoperative treatment between 1966 and 1976. The records of this group were reviewed retrospectively. Sixteen characteristics of the patient and tumor were analyzed for prognostic significance by univariate and multivariate techniques. Tumor grade, the presence of residual disease, and patient performance status are identified as stage-specific independent prognostic factors. These independent factors define patient subsets with good, intermediate, and poor prognosis within each stage. The results show that more effective treatment strategies are required for patients in poor prognosis subsets. Estimates of tumor grade, extent of residual disease, and performance status should be included in reports of treatment outcome.




This article has been cited by other articles:


Home page
 The OncologistHome page
D. Pectasides, E. Pectasides, A. Psyrri, and T. Economopoulos
Treatment Issues in Clear Cell Carcinoma of the Ovary: A Different Entity?
Oncologist, November 1, 2006; 11(10): 1089 - 1094.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
D. Pectasides, M. Pectasides, and T. Economopoulos
Brain metastases from epithelial ovarian cancer: a review of the literature.
Oncologist, March 1, 2006; 11(3): 252 - 260.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
J. K. Chan, V. Loizzi, Y. G. Lin, K. Osann, W. R. Brewster, and P. J. DiSaia
Stages III and IV Invasive Epithelial Ovarian Carcinoma in Younger Versus Older Women: What Prognostic Factors Are Important?
Obstet. Gynecol., July 1, 2003; 102(1): 156 - 161.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
S. Tingulstad, F. E. Skjeldestad, T. B. Halvorsen, and B. Hagen
Survival and Prognostic Factors in Patients With Ovarian Cancer
Obstet. Gynecol., May 1, 2003; 101(5): 885 - 891.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by the American College of Obstetricians and Gynecologists.